$35.12
0.48% day before yesterday
Nasdaq, Dec 27, 10:15 pm CET
ISIN
US88023B1035
Symbol
TEM

Tempus AI Stock price

$35.12
-27.86 44.24% 1M
+4.29 13.92% 6M
-5.13 12.75% YTD
-5.13 12.75% 1Y
-5.13 12.75% 3Y
-5.13 12.75% 5Y
-5.13 12.75% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.17 0.48%
ISIN
US88023B1035
Symbol
TEM

Key metrics

Market capitalization $5.53b
Enterprise Value $5.52b
P/B ratio (TTM) P/B ratio 101.53
Cash position $466.32m
Short interest 4.27%

Is Tempus AI a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Tempus AI Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Tempus AI forecast:

8x Buy
73%
3x Hold
27%

Analyst Opinions

11 Analysts have issued a Tempus AI forecast:

Buy
73%
Hold
27%

Financial data from Tempus AI

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
181 181
-
100%
- Direct Costs 78 78
-
43%
103 103
-
57%
- Selling and Administrative Expenses 89 89
-
49%
- Research and Development Expense 58 58
-
32%
-44 -44
-
-24%
- Depreciation and Amortization 9.44 9.44
-
5%
EBIT (Operating Income) EBIT -54 -54
-
-30%
Net Profit -76 -76
-
-42%

In millions USD.

Don't miss a Thing! We will send you all news about Tempus AI directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tempus AI Stock News

Negative
CNBC
5 days ago
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Negative
MarketBeat
9 days ago
In mid-August, around two months after Tempus AI's NASDAQ: TEM initial public offering (IPO), the stock was up a marvelous 93%. However, shares have experienced wild volatility and are now 8% below their opening price of $37 as of the Dec. 18 close.
Neutral
Business Wire
11 days ago
CHICAGO--(BUSINESS WIRE)--Tempus, a technology company leading the adoption of AI to advance precision medicine and patient care, today announced that the company has signed agreements for in-network provider status with Blue Cross Blue Shield (BCBS) of Illinois, Blue Shield of California, and Avalon Healthcare Solutions, a laboratory benefit manager. As part of the agreement with Avalon, Tempu...
More Tempus AI News

Company Profile

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Head office United States
CEO Eric Lefkofsky
Website www.tempus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today